Acadian Asset Management
XBIT icon

Acadian Asset Management’s XBiotech XBIT Stock Holding History

Acadian Asset Management’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,966
Closed -$35K – 1877
2023
Q2 		$35K Sell
5,966
-18,184
-75% -$82K ﹤0.01% 1571
2023
Q1 		$82K Sell
24,150
-13,426
-36% -$50K ﹤0.01% 1434
2022
Q4 		$130K Sell
37,576
-7,874
-17% -$26.8K ﹤0.01% 1381
2022
Q3 		$163K Sell
45,450
-4,047
-8% -$19.1K ﹤0.01% 1260
2022
Q2 		$278K Buy
+49,497
New +$333K ﹤0.01% 1117

Other funds holding XBIT

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management's XBIT Position: Q3 2023 in Review

Acadian Asset Management sold out of XBiotech (XBIT) in Q3 2023, closing a stake of 5,966 shares — an estimated $35K sold.

Acadian Asset Management first reported a position in XBIT in Q2 2022 and held it in 5 quarters. The position peaked at $278K in Q2 2022. 37 funds tracked by Wall St. Rank hold XBIT as of Q3 2023.

  • Acadian Asset Management reported no remaining XBiotech position as of Q3 2023 after selling out during the quarter.
  • Acadian Asset Management sold 5,966 XBiotech shares in Q3 2023, an estimated $35K.
  • Acadian Asset Management first reported a position in XBiotech in Q2 2022 and held it in 5 quarters.
  • Acadian Asset Management's XBiotech position peaked at $278K in Q2 2022.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q3 2023.

Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.